Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.33 |
| ▸ | CHAT | P28329 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 2/20 | 0.31 |
| ▸ | MAOB | P27338 | 2/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28697334 | 0.80 | CHAT (0.35) | NFE2L2CHATMAOAMAOBCYP19A1 | |
| SCHEMBL9344854 | 0.78 | MAOB (0.37) | NFE2L2CHATMAOAMAOBCYP19A1 | |
| SCHEMBL4438933 | 0.78 | MAOB (0.39) | NFE2L2CHATMAOAMAOBCYP19A1 | |
| SCHEMBL7324466 | 0.77 | TRPA1 (0.37) | NFE2L2CHATMAOAMAOBCYP19A1 | |
| Hydrochloric Acid SCHEMBL12003783 | 0.76 | MAOB (0.38) | NFE2L2CHATMAOAMAOBCYP19A1 | |
| Water SCHEMBL27514626 | 0.76 | MAOB (0.38) | NFE2L2CHATMAOAMAOBCYP19A1 | |
| SCHEMBL17651157 | 0.74 | GLA (0.34) | — | |
| SCHEMBL29136474 | 0.73 | TRPA1 (0.38) | NFE2L2CHAT | |
| SCHEMBL6837817 | 0.73 | CHAT (0.35) | NFE2L2CHATMAOAMAOBCYP19A1 | |
| SCHEMBL31506486 | 0.73 | CHAT (0.35) | NFE2L2CHATMAOAMAOBCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160096852-A1 | Synthesis of 4-(pentafluorosulfanyl)benzenediazonium tetrafluoroborate and Analogs | UNIVERSITY OF NORTH FLORIDA (US) | 2016-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160096852-A1 | Synthesis of 4-(pentafluorosulfanyl)benzenediazonium tetrafluoroborate and Analogs | HCK, NEK5, SIK2 | NFE2L2 2658/4885CHAT 4042/4885MAOA 4538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.